Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

Most people who own a smartwatch or ring can tell you their heart rate variability score. Few can tell you what to do about it. Vilo's Signal OS is built for that gap.

For most small business owners at the growth stage, a CFO is either absent or unaffordable. The financial clarity, cash-flow visibility, and management discipline that a CFO brings to a larger ...

NVIDIA diffusion language model Nemotron TwoTower achieves 2.42x LLM inference throughput without a full retraining run, ...

Why the Fortune 500 Companies Winning the AI Race Specialized Before They Scaled Eight in ten CEOs now say their role is at ...

The same company that raised its dividend is presiding over a franchisee system suffering from inflation, tariff disruption ...

The AI gold rush continues in mid-2026, with companies racing to turn flashy models into actual money-making systems. While ...

The pace of AI adoption is moving incredibly fast. Customers have moved well beyond experimentation and understand the importance of adopting AI to transform their business. They are now concentrating ...

Consumer health giant Haleon has tapped Microsoft to incorporate AI across its operations, joining a growing wave of healthcare and life sciences heavyweights turning to Big Tech ...

Machine learning models that use electronic health record data to predict obstructive sleep apnea had greater performance than two screening questionnaires, according to a poster presented at SLEEP ...

Finance leaders are investing record sums in technology and AI, with most CFOs naming digital transformation their top priority for 2026. Yet a growing number of programs hit every technical milestone ...